Ardelyx reported $-27807000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2912M 534M
Amgen AMGN:US $ 2500M 196M
Ardelyx ARDX:US $ -27.81M 7.47M
Astrazeneca AZN:US 878M 1.17B
Biocept BIOC:US $ -2.71M 0.07M
Chimerix CMRX:US -24771000 14.76M
Corcept Therapeutics CORT:US $ 26.77M 9.9M
Curis CRIS:US $ -15.13M 2.57M
Life Technologies LIFE:US $ -12.38M 3.74M
Opko Health OPK:US $ -72.42M 9.34M
Tg Therapeutics TGTX:US $ -66.87M 26.08M
United Therapeutics UTHR:US $ 286.3M 116.5M
Xoma XOMA:US $ -2065000 32.43M